As Patent Expirations Loom, the Clock Is Ticking on AbbVie Stock Investorplace.com
AbbVie is doing all it can to keep Humira sales high, but competition and regulation mean the party could be ending for AbbVie stock.
As Patent Expirations Loom, the Clock Is Ticking on AbbVie Stock Investorplace.com
AbbVie is doing all it can to keep Humira sales high, but competition and regulation mean the party could be ending for AbbVie stock.